Temasek-backed Vertex Ventures announced that its healthcare-focused venture capital arm Vertex Ventures HC (VVHC), has launched a $200 million Fund III to support life sciences and medical technology companies.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in
